Press Releases ProstaLund AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 06:13:41 24/05/2024 pm IST			5-day change	1st Jan Change
0.566 ^SEK	+4.43%		-13.46%	-65.28%

16/05	ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
08/04	ProstaLund AB Presents Two New Studies with Schelin Catheter	CI

ProstaLund AB - Interim report January-March 2024	16/05	AQ
ProstaLund hosted unannounced audit by TÜV SÜD	12/04	AQ
Two new studies with ProstaLund´s Schelin Catheter® presented at EAU24 in Paris	08/04	AQ
Schelin Catheter® - new study confirms efficiency and ease of use	27/02	AQ
Year-end report – ProstaLund AB (publ)	16/02	AQ
New agreement - Esbjerg Hospital starts up with CoreTherm® treatments	12/12	AQ
Interim report - ProstaLund AB (publ)	07/11	AQ
Schelin Catheter® has had its premiere in France.	11/23/11	AQ
Schelin Catheter® beneficial together with TURP	05/23/05	AQ
ProstaLund signs sales agent agreement for France	31/23/31	AQ
Patent has been approved in China	15/23/15	AQ
Very strong sales in the quarter, + 53 %	14/23/14	AQ
ProstaLund decides to withdraw its 510(k) application and intend instead to submit a De Novo application for Schelin Catheter® in the US	11/23/11	AQ
Schelin Catheter® breaking new ground again	05/23/05	AQ
Schelin Catheter® has been approved in Switzerland	17/23/17	AQ
Case report on CoreFlow Soft Stent® published	01/23/01	AQ
First Schelin Catheter®-assisted TURPs performed in Brazil	22/23/22	AQ
22% sales growth in the quarter	17/23/17	AQ
Schelin Catheter® approved in Hainan, China	25/23/25	AQ
ProstaLund signs distribution agreement for Poland	25/23/25	AQ

No results for this search